Global Deep Vein Thrombosis (DVT) Therapy Market Growth (Status and Outlook) 2025-2031

According to this study, the global Deep Vein Thrombosis (DVT) Therapy market size will reach US$ 1388 million by 2031.

Treatment options for deep vein thrombosis include: Medication—blood thinners. These medications, also called anticoagulants, help prevent blood clots from growing in size. Blood thinners reduce the risk of developing more blood clots. Filter, a filter is placed in the large vein in the abdomen (the vena cava). Vena cava filters prevent dislodged blood clots from becoming lodged in the lungs. Compression therapy - leggings (compression stockings). These special stockings help prevent blood from pooling in the legs, thereby reducing leg swelling. Pull the stockings up your legs from your feet to your knees. People with deep vein thrombosis usually need to wear these socks during the day and for several years if possible.

LPI (LP Information)' newest research report, the “Deep Vein Thrombosis (DVT) Therapy Industry Forecast” looks at past sales and reviews total world Deep Vein Thrombosis (DVT) Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Deep Vein Thrombosis (DVT) Therapy sales for 2025 through 2031. With Deep Vein Thrombosis (DVT) Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Deep Vein Thrombosis (DVT) Therapy industry.

This Insight Report provides a comprehensive analysis of the global Deep Vein Thrombosis (DVT) Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Deep Vein Thrombosis (DVT) Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Deep Vein Thrombosis (DVT) Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Deep Vein Thrombosis (DVT) Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Deep Vein Thrombosis (DVT) Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Deep Vein Thrombosis (DVT) Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:
Drugs
Vena Cava Filters
Compression Therapy

Segmentation by Application:
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boston Scientific
Inari Medical
JETi
C.R. Bard (BD)
Bayer
B. Braun

Please note: The report will take approximately 2 business days to prepare and deliver. Show more